Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Nat Rev Neurol. 2018 Dec;14(12):723-734. doi: 10.1038/s41582-018-0095-7.
The contributions of the peripheral adaptive and innate immune systems to CNS autoimmunity have been extensively studied. However, the role of thymic selection in these conditions is much less well understood. The thymus is the primary lymphoid organ for the generation of T cells; thymic mechanisms ensure that cells with an overt autoreactive specificity are eliminated before they emigrate to the periphery and control the generation of thymic regulatory T cells. Evidence from animal studies demonstrates that thymic T cell selection is important for establishing tolerance to autoantigens. However, there is a considerable knowledge gap regarding the role of thymic selection in autoimmune conditions of the human CNS. In this Review, we critically examine the current body of experimental evidence for the contribution of thymic tolerance to CNS autoimmune diseases. An understanding of why dysfunction of either thymic or peripheral tolerance mechanisms rarely leads to CNS inflammation is currently lacking. We examine the potential of de novo T cell formation and thymic selection as novel therapeutic avenues and highlight areas for future study that are likely to make these targets the focus of future treatments.
外周适应性和固有免疫系统对中枢神经系统自身免疫的贡献已经得到了广泛的研究。然而,胸腺选择在这些情况下的作用却知之甚少。胸腺是 T 细胞生成的主要淋巴器官; 胸腺机制确保了具有明显自身反应性特异性的细胞在迁移到外周之前被清除,并控制胸腺调节性 T 细胞的生成。来自动物研究的证据表明,胸腺 T 细胞选择对于建立对自身抗原的耐受至关重要。然而,关于胸腺选择在人类中枢神经系统自身免疫性疾病中的作用,仍存在相当大的知识空白。在这篇综述中,我们批判性地检查了目前关于胸腺耐受对中枢神经系统自身免疫性疾病贡献的实验证据。目前还不清楚为什么胸腺或外周耐受机制的功能障碍很少导致中枢神经系统炎症。我们探讨了新的 T 细胞形成和胸腺选择作为新的治疗途径的潜力,并强调了未来可能使这些靶点成为未来治疗焦点的研究领域。